BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10747038)

  • 1. Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repair.
    Oda S; Humbert O; Fiumicino S; Bignami M; Karran P
    EMBO J; 2000 Apr; 19(7):1711-8. PubMed ID: 10747038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MutSalpha in the recognition of iododeoxyuridine in DNA.
    Berry SE; Loh T; Yan T; Kinsella TJ
    Cancer Res; 2003 Sep; 63(17):5490-5. PubMed ID: 14500385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
    Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
    Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
    Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
    Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
    Christmann M; Kaina B
    J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
    Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
    Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA loop repair by human cell extracts.
    Umar A; Boyer JC; Kunkel TA
    Science; 1994 Nov; 266(5186):814-6. PubMed ID: 7973637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mlh1 can function in antibody class switch recombination independently of Msh2.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2003 May; 197(10):1377-83. PubMed ID: 12743174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling mismatch repair in cancer.
    Fishel R
    Nat Med; 1999 Nov; 5(11):1239-41. PubMed ID: 10545986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four novel MSH2 / MLH1 gene mutations in portuguese HNPCC families.
    Isidro G; Veiga I; Matos P; Almeida S; Bizarro S; Marshall B; Baptista M; Leite J; Regateiro F; Soares J; Castedo S; Boavida MG
    Hum Mutat; 2000 Jan; 15(1):116. PubMed ID: 10612836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair.
    Leadon SA; Avrutskaya AV
    Cancer Res; 1997 Sep; 57(17):3784-91. PubMed ID: 9288788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of DNA mismatch repair in platinum drug resistance.
    Fink D; Nebel S; Aebi S; Zheng H; Cenni B; Nehmé A; Christen RD; Howell SB
    Cancer Res; 1996 Nov; 56(21):4881-6. PubMed ID: 8895738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of yeast pms1, msh2, and mlh1 mutators points to differences in mismatch correction efficiencies between prokaryotic and eukaryotic cells.
    Yang Y; Karthikeyan R; Mack SE; Vonarx EJ; Kunz BA
    Mol Gen Genet; 1999 Jun; 261(4-5):777-87. PubMed ID: 10394915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair.
    Gu L; Hong Y; McCulloch S; Watanabe H; Li GM
    Nucleic Acids Res; 1998 Mar; 26(5):1173-8. PubMed ID: 9469823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of DNA mismatch repair genes in naevi.
    Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
    In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells.
    Fedier A; Fowst C; Tursi J; Geroni C; Haller U; Marchini S; Fink D
    Br J Cancer; 2003 Oct; 89(8):1559-65. PubMed ID: 14562032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
    Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
    Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.
    Genschel J; Littman SJ; Drummond JT; Modrich P
    J Biol Chem; 1998 Jul; 273(31):19895-901. PubMed ID: 9677427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.